142 related articles for article (PubMed ID: 3012375)
61. Magnesium inhibits human platelets.
Ravn HB; Kristensen SD; Vissinger H; Husted SE
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):241-4. PubMed ID: 8735829
[TBL] [Abstract][Full Text] [Related]
62. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
63. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
64. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
Cofrancesco E; Colombi M; Gianese F; Cortellaro M
Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
[TBL] [Abstract][Full Text] [Related]
65. Relevance of platelet factor four (PF4) plasma levels in multiple sclerosis.
Cananzi AR; Ferro-Milone F; Grigoletto F; Toldo M; Meneghini F; Bortolon F; D'Andrea G
Acta Neurol Scand; 1987 Aug; 76(2):79-85. PubMed ID: 2960124
[TBL] [Abstract][Full Text] [Related]
66. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
67. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
Hsiao G; Shen MY; Fang CL; Chou DS; Lin CH; Chen TF; Sheu JR
J Biomed Sci; 2003; 10(3):292-301. PubMed ID: 12711856
[TBL] [Abstract][Full Text] [Related]
68. Enhancement of the antiaggregatory activity of prostacyclin by propranolol in human platelets.
Callahan KS; Johnson AR; Campbell WB
Circulation; 1985 Jun; 71(6):1237-46. PubMed ID: 2986877
[TBL] [Abstract][Full Text] [Related]
69. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
Sekiya K; Okuda H
Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
[TBL] [Abstract][Full Text] [Related]
70. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
[TBL] [Abstract][Full Text] [Related]
71. Platelet-released proteins as molecular markers for the activation process.
Walz DA
Semin Thromb Hemost; 1984 Oct; 10(4):270-9. PubMed ID: 6240116
[TBL] [Abstract][Full Text] [Related]
72. Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
González-Correa JA; Muñoz-Marín J; López-Villodres JA; Navas MD; Guerrero A; Torres JA; De La Cruz JP
Pharmacol Res; 2007 Aug; 56(2):168-74. PubMed ID: 17644353
[TBL] [Abstract][Full Text] [Related]
73. The increase of the openings of the surface-connected canalicular system in weakly stimulated platelets is prevented by a carbochromen derivative. A computerized morphometric analysis of freeze-etched human platelet plasma-membrane.
Bianciardi G; Toti P; Weber G
Pharmacol Res Commun; 1987 Sep; 19(9):579-89. PubMed ID: 3432323
[TBL] [Abstract][Full Text] [Related]
74. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
75. Numerical and functional modifications in platelets induced by polyester coated by a hydrophilic polymer.
Cenni E; Cavedagna D; Falsone G; Mari G; Pizzoferrato A
Biomaterials; 1993 Jul; 14(8):588-90. PubMed ID: 8399951
[TBL] [Abstract][Full Text] [Related]
76. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
Ding YA; Chou TC; Lin KC
J Hum Hypertens; 1994 Apr; 8(4):273-8. PubMed ID: 8021907
[TBL] [Abstract][Full Text] [Related]
77. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
78. Effect of storage on platelet release and aggregation responses.
Scott NJ; Harris JR; Bolton AE
Vox Sang; 1983; 45(5):359-66. PubMed ID: 6227139
[TBL] [Abstract][Full Text] [Related]
79. Double blind study of the influence of co-dergocrine on platelet parameters in healthy volunteers.
Sinzinger H
Eur J Clin Pharmacol; 1985; 28(6):713-6. PubMed ID: 2998802
[TBL] [Abstract][Full Text] [Related]
80. Platelet BTG release in vitro induced by mechanical and chemical stimulus: correlation with the aggregation curve parameters.
Santos MT; Valles J; Aznar J; Villa P
Scand J Haematol; 1982 Nov; 29(5):368-72. PubMed ID: 6186011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
